Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
doi: 10.3390/ijms231810951 278
Peer reviewer reports are available
Adding barrier contraception during the dose-titration phase is advised, or switching to a vaginal ring or transdermal patch (160, 162)
Front Endocrinol Lausanne
This is based on its ability to counteract ketamine and MK-801, NMDA receptor antagonists that model negative-like schizophrenia symptoms in rodents
IGF-1 treatment: future and limitations The FDA approved the use of rhIGF-1 (Mecasermin, Increlex) for treatment of severe primary IGF-1 deficiency in 2003
US$ 20.39
US$ 25.18
US$ 25.44
US$ 20.31
US$ 23.44
US$ 26.66
